Global Radiopharmaceuticals in Nuclear Medicine Sales Market Report 2021

Global Radiopharmaceuticals in Nuclear Medicine Sales Market Report 2021

Table of Contents
1 Radiopharmaceuticals in Nuclear Medicine Market Overview
1.1 Radiopharmaceuticals in Nuclear Medicine Product Scope
1.2 Radiopharmaceuticals in Nuclear Medicine Segment by Type
1.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2016 & 2021 & 2027)
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapy Radiopharmaceuticals
1.2.4 Enriched Stable Isotopes
1.3 Radiopharmaceuticals in Nuclear Medicine Segment by Application
1.3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Diagnostic Application
1.3.3 Therapeutic Application
1.3.4 Research
1.3.5 Pharmaceutical
1.3.6 Other
1.4 Radiopharmaceuticals in Nuclear Medicine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Radiopharmaceuticals in Nuclear Medicine Price Trends (2016-2027)
2 Radiopharmaceuticals in Nuclear Medicine Estimates and Forecasts by Region
2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Radiopharmaceuticals in Nuclear Medicine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2016-2021)
2.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2016-2021)
2.3 Global Radiopharmaceuticals in Nuclear Medicine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Radiopharmaceuticals in Nuclear Medicine Estimates and Projections (2016-2027)
2.4.2 Europe Radiopharmaceuticals in Nuclear Medicine Estimates and Projections (2016-2027)
2.4.3 China Radiopharmaceuticals in Nuclear Medicine Estimates and Projections (2016-2027)
2.4.4 Japan Radiopharmaceuticals in Nuclear Medicine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Estimates and Projections (2016-2027)
2.4.6 India Radiopharmaceuticals in Nuclear Medicine Estimates and Projections (2016-2027)
3 Global Radiopharmaceuticals in Nuclear Medicine Competition Landscape by Players
3.1 Global Top Radiopharmaceuticals in Nuclear Medicine Players by Sales (2016-2021)
3.2 Global Top Radiopharmaceuticals in Nuclear Medicine Players by Revenue (2016-2021)
3.3 Global Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceuticals in Nuclear Medicine as of 2020)
3.4 Global Radiopharmaceuticals in Nuclear Medicine Average Price by Company (2016-2021)
3.5 Manufacturers Radiopharmaceuticals in Nuclear Medicine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Type
4.1 Global Radiopharmaceuticals in Nuclear Medicine Historic Market Review by Type (2016-2021)
4.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2016-2021)
4.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2016-2021)
4.1.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2016-2021)
4.2 Global Radiopharmaceuticals in Nuclear Medicine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Type (2022-2027)
4.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Type (2022-2027)
4.2.3 Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Type (2022-2027)
5 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Application
5.1 Global Radiopharmaceuticals in Nuclear Medicine Historic Market Review by Application (2016-2021)
5.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2016-2021)
5.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2016-2021)
5.1.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Application (2016-2021)
5.2 Global Radiopharmaceuticals in Nuclear Medicine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Application (2022-2027)
5.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Application (2022-2027)
5.2.3 Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Application (2022-2027)
6 North America Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures
6.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Company
6.1.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Company (2016-2021)
6.1.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021)
6.2 North America Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type
6.2.1 North America Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2016-2021)
6.2.2 North America Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2022-2027)
6.3 North America Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application
6.3.1 North America Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application (2016-2021)
6.3.2 North America Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application (2022-2027)
7 Europe Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures
7.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Company
7.1.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Company (2016-2021)
7.1.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021)
7.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type
7.2.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2022-2027)
7.3 Europe Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application
7.3.1 Europe 154 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 154 Sales Breakdown by Application (2022-2027)
8 China Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures
8.1 China Radiopharmaceuticals in Nuclear Medicine Sales by Company
8.1.1 China Radiopharmaceuticals in Nuclear Medicine Sales by Company (2016-2021)
8.1.2 China Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021)
8.2 China Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type
8.2.1 China Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2016-2021)
8.2.2 China Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2022-2027)
8.3 China Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application
8.3.1 China 173 Sales Breakdown by Application (2016-2021)
8.3.2 China 173 Sales Breakdown by Application (2022-2027)
9 Japan Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures
9.1 Japan Radiopharmaceuticals in Nuclear Medicine Sales by Company
9.1.1 Japan Radiopharmaceuticals in Nuclear Medicine Sales by Company (2016-2021)
9.1.2 Japan Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021)
9.2 Japan Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type
9.2.1 Japan Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2022-2027)
9.3 Japan Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures
10.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales by Company
10.1.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales by Company (2016-2021)
10.1.2 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021)
10.2 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type
10.2.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures
11.1 India Radiopharmaceuticals in Nuclear Medicine Sales by Company
11.1.1 India Radiopharmaceuticals in Nuclear Medicine Sales by Company (2016-2021)
11.1.2 India Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021)
11.2 India Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type
11.2.1 India Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2016-2021)
11.2.2 India Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2022-2027)
11.3 India Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application
11.3.1 India Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application (2016-2021)
11.3.2 India Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Radiopharmaceuticals in Nuclear Medicine Business
12.1 Bracco Imaging S.P.A.
12.1.1 Bracco Imaging S.P.A. Corporation Information
12.1.2 Bracco Imaging S.P.A. Business Overview
12.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Products Offered
12.1.5 Bracco Imaging S.P.A. Recent Development
12.2 Cambridge Isotope Laboratories, Inc.
12.2.1 Cambridge Isotope Laboratories, Inc. Corporation Information
12.2.2 Cambridge Isotope Laboratories, Inc. Business Overview
12.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
12.2.5 Cambridge Isotope Laboratories, Inc. Recent Development
12.3 Cardinal Health, Inc.
12.3.1 Cardinal Health, Inc. Corporation Information
12.3.2 Cardinal Health, Inc. Business Overview
12.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
12.3.5 Cardinal Health, Inc. Recent Development
12.4 Covidien, Plc
12.4.1 Covidien, Plc Corporation Information
12.4.2 Covidien, Plc Business Overview
12.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Products Offered
12.4.5 Covidien, Plc Recent Development
12.5 Eczacibasi-Monrol
12.5.1 Eczacibasi-Monrol Corporation Information
12.5.2 Eczacibasi-Monrol Business Overview
12.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Products Offered
12.5.5 Eczacibasi-Monrol Recent Development
12.6 Fujifilm Holdings Corporation
12.6.1 Fujifilm Holdings Corporation Corporation Information
12.6.2 Fujifilm Holdings Corporation Business Overview
12.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Products Offered
12.6.5 Fujifilm Holdings Corporation Recent Development
12.7 GE Healthcare (Subsidiary Of General Electric Company)
12.7.1 GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
12.7.2 GE Healthcare (Subsidiary Of General Electric Company) Business Overview
12.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Products Offered
12.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development
12.8 IBA Group
12.8.1 IBA Group Corporation Information
12.8.2 IBA Group Business Overview
12.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Products Offered
12.8.5 IBA Group Recent Development
12.9 Isotec, Inc. (Sigma-Aldrich)
12.9.1 Isotec, Inc. (Sigma-Aldrich) Corporation Information
12.9.2 Isotec, Inc. (Sigma-Aldrich) Business Overview
12.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Products Offered
12.9.5 Isotec, Inc. (Sigma-Aldrich) Recent Development
12.10 Lantheus Medical Imaging, Inc.
12.10.1 Lantheus Medical Imaging, Inc. Corporation Information
12.10.2 Lantheus Medical Imaging, Inc. Business Overview
12.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
12.10.5 Lantheus Medical Imaging, Inc. Recent Development
12.11 Nordion, Inc.
12.11.1 Nordion, Inc. Corporation Information
12.11.2 Nordion, Inc. Business Overview
12.11.3 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
12.11.5 Nordion, Inc. Recent Development
12.12 Ntp Radioisotopes (Pty), Ltd.
12.12.1 Ntp Radioisotopes (Pty), Ltd. Corporation Information
12.12.2 Ntp Radioisotopes (Pty), Ltd. Business Overview
12.12.3 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Products Offered
12.12.5 Ntp Radioisotopes (Pty), Ltd. Recent Development
12.13 Siemens Healthcare (Subsidiary Of Siemens AG)
12.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Corporation Information
12.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Business Overview
12.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Products Offered
12.13.5 Siemens Healthcare (Subsidiary Of Siemens AG) Recent Development
12.14 Taiyo Nippon Sanso Corporation
12.14.1 Taiyo Nippon Sanso Corporation Corporation Information
12.14.2 Taiyo Nippon Sanso Corporation Business Overview
12.14.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Products Offered
12.14.5 Taiyo Nippon Sanso Corporation Recent Development
12.15 Urenco Limited
12.15.1 Urenco Limited Corporation Information
12.15.2 Urenco Limited Business Overview
12.15.3 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Products Offered
12.15.5 Urenco Limited Recent Development
12.16 Rotem Industries, Ltd., Inc.
12.16.1 Rotem Industries, Ltd., Inc. Corporation Information
12.16.2 Rotem Industries, Ltd., Inc. Business Overview
12.16.3 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
12.16.5 Rotem Industries, Ltd., Inc. Recent Development
12.17 Australian Nuclear Association And Technology Organization (ANSTO)
12.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Corporation Information
12.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Business Overview
12.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Products Offered
12.17.5 Australian Nuclear Association And Technology Organization (ANSTO) Recent Development
12.18 Board of Radiation And Isotope Technology (BRIT)
12.18.1 Board of Radiation And Isotope Technology (BRIT) Corporation Information
12.18.2 Board of Radiation And Isotope Technology (BRIT) Business Overview
12.18.3 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Products Offered
12.18.5 Board of Radiation And Isotope Technology (BRIT) Recent Development
12.19 Institute of Atomic Energy Polatom Radioisotope Centre
12.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Corporation Information
12.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Business Overview
12.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Products Offered
12.19.5 Institute of Atomic Energy Polatom Radioisotope Centre Recent Development
12.20 Institute of Isotopes Co., Ltd.
12.20.1 Institute of Isotopes Co., Ltd. Corporation Information
12.20.2 Institute of Isotopes Co., Ltd. Business Overview
12.20.3 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Products Offered
12.20.5 Institute of Isotopes Co., Ltd. Recent Development
12.21 Institute Of Radioelement (IRE)
12.21.1 Institute Of Radioelement (IRE) Corporation Information
12.21.2 Institute Of Radioelement (IRE) Business Overview
12.21.3 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Products Offered
12.21.5 Institute Of Radioelement (IRE) Recent Development
13 Radiopharmaceuticals in Nuclear Medicine Manufacturing Cost Analysis
13.1 Radiopharmaceuticals in Nuclear Medicine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine
13.4 Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Radiopharmaceuticals in Nuclear Medicine Distributors List
14.3 Radiopharmaceuticals in Nuclear Medicine Customers
15 Market Dynamics
15.1 Radiopharmaceuticals in Nuclear Medicine Market Trends
15.2 Radiopharmaceuticals in Nuclear Medicine Drivers
15.3 Radiopharmaceuticals in Nuclear Medicine Market Challenges
15.4 Radiopharmaceuticals in Nuclear Medicine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Radiopharmaceuticals in Nuclear Medicine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Radiopharmaceuticals in Nuclear Medicine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Radiopharmaceuticals in Nuclear Medicine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Region (2016-2021)
Table 5. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2016-2021)
Table 6. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Region (2016-2021)
Table 8. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Company (2016-2021)
Table 14. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Company (2016-2021)
Table 16. Global Radiopharmaceuticals in Nuclear Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceuticals in Nuclear Medicine as of 2020)
Table 17. Global Radiopharmaceuticals in Nuclear Medicine Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Radiopharmaceuticals in Nuclear Medicine Manufacturing Sites and Area Served
Table 19. Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Type (2016-2021)
Table 22. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Type (2016-2021)
Table 23. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Radiopharmaceuticals in Nuclear Medicine Price (USD/MT) by Type (2016-2021)
Table 25. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Type (2022-2027)
Table 26. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type (2022-2027)
Table 28. Global Radiopharmaceuticals in Nuclear Medicine Price (USD/MT) by Type (2022-2027)
Table 29. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Application (2016-2021)
Table 30. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Application (2016-2021)
Table 31. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Radiopharmaceuticals in Nuclear Medicine Price (USD/MT) by Application (2016-2021)
Table 33. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Application (2022-2027)
Table 34. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Application (2022-2027)
Table 35. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Application (2022-2027)
Table 37. Global Radiopharmaceuticals in Nuclear Medicine Price (USD/MT) by Application (2022-2027)
Table 38. North America Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Company (2016-2021)
Table 39. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Company (2016-2021)
Table 40. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Company (2016-2021)
Table 42. North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2016-2021) & (K MT)
Table 43. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2016-2021)
Table 44. North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2022-2027) & (K MT)
Table 45. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2022-2027)
Table 46. North America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2016-2021) & (K MT)
Table 47. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2016-2021)
Table 48. North America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2022-2027) & (K MT)
Table 49. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2022-2027)
Table 50. Europe Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Company (2016-2021)
Table 51. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Company (2016-2021)
Table 52. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Company (2016-2021)
Table 54. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2016-2021) & (K MT)
Table 55. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2016-2021)
Table 56. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2022-2027) & (K MT)
Table 57. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2022-2027)
Table 58. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2016-2021) & (K MT)
Table 59. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2016-2021)
Table 60. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2022-2027) & (K MT)
Table 61. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2022-2027)
Table 62. China Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Company (2016-2021)
Table 63. China Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Company (2016-2021)
Table 64. China Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Company (2016-2021)
Table 66. China Radiopharmaceuticals in Nuclear Medicine Sales by Type (2016-2021) & (K MT)
Table 67. China Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2016-2021)
Table 68. China Radiopharmaceuticals in Nuclear Medicine Sales by Type (2022-2027) & (K MT)
Table 69. China Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2022-2027)
Table 70. China Radiopharmaceuticals in Nuclear Medicine Sales by Application (2016-2021) & (K MT)
Table 71. China Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2016-2021)
Table 72. China Radiopharmaceuticals in Nuclear Medicine Sales by Application (2022-2027) & (K MT)
Table 73. China Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2022-2027)
Table 74. Japan Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Company (2016-2021)
Table 75. Japan Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Company (2016-2021)
Table 76. Japan Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Company (2016-2021)
Table 78. Japan Radiopharmaceuticals in Nuclear Medicine Sales by Type (2016-2021) & (K MT)
Table 79. Japan Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2016-2021)
Table 80. Japan Radiopharmaceuticals in Nuclear Medicine Sales by Type (2022-2027) & (K MT)
Table 81. Japan Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2022-2027)
Table 82. Japan Radiopharmaceuticals in Nuclear Medicine Sales by Application (2016-2021) & (K MT)
Table 83. Japan Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2016-2021)
Table 84. Japan Radiopharmaceuticals in Nuclear Medicine Sales by Application (2022-2027) & (K MT)
Table 85. Japan Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2022-2027)
Table 98. India Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Company (2016-2021)
Table 99. India Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Company (2016-2021)
Table 100. India Radiopharmaceuticals in Nuclear Medicine R

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs